Global Mesalazine Market Insights and Forecast to 2031

Report ID: 863335 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
1 Study Coverage
    1.1 Mesalazine Product Introduction
    1.2 Market by Type
        1.2.1 Global Mesalazine Market Size Growth Rate by Type
        1.4.2 Purity ≥ 97 %
        1.4.3 Purity ≥ 98 %
        1.2.4 Purity ≥ 99 %
    1.3 Market by Application
        1.3.1 Global Mesalazine Market Size Growth Rate by Application
        1.3.2 Mesalazine Tablets
        1.3.3 Mesalazine Capsules
        1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Mesalazine Sales Estimates and Forecasts 2016-2027
    2.2 Global Mesalazine Revenue Estimates and Forecasts 2016-2027
    2.3 Global Mesalazine Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Mesalazine Regions by Sales
        2.4.1 Global Top Mesalazine Regions by Sales (2016-2021)
        2.4.2 Global Top Mesalazine Regions by Sales (2022-2027)
    2.5 Global Top Mesalazine Regions by Revenue
        2.5.1 Global Top Mesalazine Regions by Revenue (2016-2021)
        2.5.2 Global Top Mesalazine Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Mesalazine Sales by Manufacturers
        3.1.1 Global Top Mesalazine Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Mesalazine Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Mesalazine Sales in 2020
    3.2 Global Mesalazine Revenue by Manufacturers
        3.2.1 Global Top Mesalazine Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Mesalazine Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Mesalazine Revenue in 2020
    3.3 Global Mesalazine Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Mesalazine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Mesalazine Sales by Type
        4.1.1 Global Mesalazine Historical Sales by Type (2016-2021)
        4.1.2 Global Mesalazine Forecasted Sales by Type (2022-2027)
        4.1.3 Global Mesalazine Sales Market Share by Type (2016-2027)
    4.2 Global Mesalazine Revenue by Type
        4.2.1 Global Mesalazine Historical Revenue by Type (2016-2021)
        4.2.2 Global Mesalazine Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Mesalazine Revenue Market Share by Type (2016-2027)
    4.3 Global Mesalazine Price by Type
        4.3.1 Global Mesalazine Price by Type (2016-2021)
        4.3.2 Global Mesalazine Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Mesalazine Sales by Application
        5.1.1 Global Mesalazine Historical Sales by Application (2016-2021)
        5.1.2 Global Mesalazine Forecasted Sales by Application (2022-2027)
        5.1.3 Global Mesalazine Sales Market Share by Application (2016-2027)
    5.2 Global Mesalazine Revenue by Application
        5.2.1 Global Mesalazine Historical Revenue by Application (2016-2021)
        5.2.2 Global Mesalazine Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Mesalazine Revenue Market Share by Application (2016-2027)
    5.3 Global Mesalazine Price by Application
        5.3.1 Global Mesalazine Price by Application (2016-2021)
        5.3.2 Global Mesalazine Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Mesalazine Market Size by Type
        6.1.1 North America Mesalazine Sales by Type (2016-2027)
        6.1.2 North America Mesalazine Revenue by Type (2016-2027)
    6.2 North America Mesalazine Market Size by Application
        6.2.1 North America Mesalazine Sales by Application (2016-2027)
        6.2.2 North America Mesalazine Revenue by Application (2016-2027)
    6.3 North America Mesalazine Market Size by Country
        6.3.1 North America Mesalazine Sales by Country (2016-2027)
        6.3.2 North America Mesalazine Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Mesalazine Market Size by Type
        7.1.1 Europe Mesalazine Sales by Type (2017-2027)
        7.1.2 Europe Mesalazine Revenue by Type (2017-2027)
    7.2 Europe Mesalazine Market Size by Application
        7.2.1 Europe Mesalazine Sales by Application (2017-2027)
        7.2.2 Europe Mesalazine Revenue by Application (2017-2027)
    7.3 Europe Mesalazine Market Size by Country
        7.3.1 Europe Mesalazine Sales by Country (2017-2027)
        7.3.2 Europe Mesalazine Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Mesalazine Market Size by Type
        8.1.1 Asia Pacific Mesalazine Sales by Type (2018-2027)
        8.1.2 Asia Pacific Mesalazine Revenue by Type (2018-2027)
    8.2 Asia Pacific Mesalazine Market Size by Application
        8.2.1 Asia Pacific Mesalazine Sales by Application (2018-2027)
        8.2.2 Asia Pacific Mesalazine Revenue by Application (2018-2027)
    8.3 Asia Pacific Mesalazine Market Size by Region
        8.3.1 Asia Pacific Mesalazine Sales by Region (2018-2027)
        8.3.2 Asia Pacific Mesalazine Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Mesalazine Market Size by Type
        9.1.1 Latin America Mesalazine Sales by Type (2019-2027)
        9.1.2 Latin America Mesalazine Revenue by Type (2019-2027)
    9.2 Latin America Mesalazine Market Size by Application
        9.2.1 Latin America Mesalazine Sales by Application (2019-2027)
        9.2.2 Latin America Mesalazine Revenue by Application (2019-2027)
    9.3 Latin America Mesalazine Market Size by Country
        9.3.1 Latin America Mesalazine Sales by Country (2019-2027)
        9.3.2 Latin America Mesalazine Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Mesalazine Market Size by Type
        6.1.1 Middle East and Africa Mesalazine Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Mesalazine Revenue by Type (2016-2027)
    6.2 Middle East and Africa Mesalazine Market Size by Application
        6.2.1 Middle East and Africa Mesalazine Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Mesalazine Revenue by Application (2016-2027)
    6.3 Middle East and Africa Mesalazine Market Size by Country
        6.3.1 Middle East and Africa Mesalazine Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Mesalazine Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Syntese A/S
        11.1.1 Syntese A/S Corporation Information
        11.1.2 Syntese A/S Overview
        11.1.3 Syntese A/S Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Syntese A/S Mesalazine Product Description
        11.1.5 Syntese A/S Related Developments
    11.2 Divis Laboratories
        11.2.1 Divis Laboratories Corporation Information
        11.2.2 Divis Laboratories Overview
        11.2.3 Divis Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Divis Laboratories Mesalazine Product Description
        11.2.5 Divis Laboratories Related Developments
    11.3 Cambrex Corporation
        11.3.1 Cambrex Corporation Corporation Information
        11.3.2 Cambrex Corporation Overview
        11.3.3 Cambrex Corporation Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Cambrex Corporation Mesalazine Product Description
        11.3.5 Cambrex Corporation Related Developments
    11.4 Ipca Laboratories
        11.4.1 Ipca Laboratories Corporation Information
        11.4.2 Ipca Laboratories Overview
        11.4.3 Ipca Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Ipca Laboratories Mesalazine Product Description
        11.4.5 Ipca Laboratories Related Developments
    11.5 PharmaZell
        11.5.1 PharmaZell Corporation Information
        11.5.2 PharmaZell Overview
        11.5.3 PharmaZell Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 PharmaZell Mesalazine Product Description
        11.5.5 PharmaZell Related Developments
    11.6 Lasa Loboratory
        11.6.1 Lasa Loboratory Corporation Information
        11.6.2 Lasa Loboratory Overview
        11.6.3 Lasa Loboratory Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Lasa Loboratory Mesalazine Product Description
        11.6.5 Lasa Loboratory Related Developments
    11.7 Erregierre SpA
        11.7.1 Erregierre SpA Corporation Information
        11.7.2 Erregierre SpA Overview
        11.7.3 Erregierre SpA Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Erregierre SpA Mesalazine Product Description
        11.7.5 Erregierre SpA Related Developments
    11.8 Corden Pharma Bergamo
        11.8.1 Corden Pharma Bergamo Corporation Information
        11.8.2 Corden Pharma Bergamo Overview
        11.8.3 Corden Pharma Bergamo Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Corden Pharma Bergamo Mesalazine Product Description
        11.8.5 Corden Pharma Bergamo Related Developments
    11.9 CTX Lifescience
        11.9.1 CTX Lifescience Corporation Information
        11.9.2 CTX Lifescience Overview
        11.9.3 CTX Lifescience Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 CTX Lifescience Mesalazine Product Description
        11.9.5 CTX Lifescience Related Developments
    11.10 Ishita Active Pharma Ingredients
        11.10.1 Ishita Active Pharma Ingredients Corporation Information
        11.10.2 Ishita Active Pharma Ingredients Overview
        11.10.3 Ishita Active Pharma Ingredients Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Ishita Active Pharma Ingredients Mesalazine Product Description
        11.10.5 Ishita Active Pharma Ingredients Related Developments
    11.1 Syntese A/S
        11.1.1 Syntese A/S Corporation Information
        11.1.2 Syntese A/S Overview
        11.1.3 Syntese A/S Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Syntese A/S Mesalazine Product Description
        11.1.5 Syntese A/S Related Developments
    11.12 Xinxiang Tianfeng Fine Chemical
        11.12.1 Xinxiang Tianfeng Fine Chemical Corporation Information
        11.12.2 Xinxiang Tianfeng Fine Chemical Overview
        11.12.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 Xinxiang Tianfeng Fine Chemical Product Description
        11.12.5 Xinxiang Tianfeng Fine Chemical Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Mesalazine Value Chain Analysis
    12.2 Mesalazine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Mesalazine Production Mode & Process
    12.4 Mesalazine Sales and Marketing
        12.4.1 Mesalazine Sales Channels
        12.4.2 Mesalazine Distributors
    12.5 Mesalazine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Mesalazine Industry Trends
    13.2 Mesalazine Market Drivers
    13.3 Mesalazine Market Challenges
    13.4 Mesalazine Market Restraints

14 Key Findings in The Global Mesalazine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Mesalazine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Purity ≥ 97 %
    Table 3. Major Manufacturers of Purity ≥ 98 %
    Table 4. Major Manufacturers of Purity ≥ 99 %
    Table 5. Global Mesalazine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 6. Global Mesalazine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Mesalazine Sales by Region (2016-2021) & (Ton)
    Table 8. Global Mesalazine Sales Market Share by Region (2016-2021)
    Table 9. Global Mesalazine Sales by Region (2016-2021) & (Ton)
    Table 10. Global Mesalazine Sales Market Share by Region (2022-2027)
    Table 11. Global Mesalazine Revenue by Region (2016-2021) & (US$ Million)
    Table 12. Global Mesalazine Revenue Market Share by Region (2016-2021)
    Table 13. Global Mesalazine Revenue by Region (2022-2027) & (US$ Million)
    Table 14. Global Mesalazine Revenue Market Share by Region (2022-2027)
    Table 15. Global Mesalazine Sales by Manufacturers (2016-2021) & (Ton)
    Table 16. Global Mesalazine Sales Share by Manufacturers (2016-2021)
    Table 17. Global Mesalazine Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 18. Global Mesalazine Revenue Share by Manufacturers (2016-2021)
    Table 19. Mesalazine Price by Manufacturers 2016-2021 (US$/Kg)
    Table 20. Global Mesalazine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Mesalazine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine as of 2020)
    Table 22. Mesalazine Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Mesalazine Product Offered
    Table 24. Date of Manufacturers Enter into Mesalazine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Mesalazine Sales by Type (2016-2021) & (Ton)
    Table 27. Global Mesalazine Sales by Type (2022-2027) & (Ton)
    Table 28. Global Mesalazine Sales Share by Type (2016-2021)
    Table 29. Global Mesalazine Sales Share by Type (2022-2027)
    Table 30. Global Mesalazine Revenue by Type (2016-2021) & (US$ Million)
    Table 31. Global Mesalazine Revenue by Type (2022-2027) & (US$ Million)
    Table 32. Global Mesalazine Revenue Share by Type (2016-2021)
    Table 33. Global Mesalazine Revenue Share by Type (2022-2027)
    Table 34. Mesalazine Price by Type (2016-2021) & (US$/Kg)
    Table 35. Global Mesalazine Price Forecast by Type (2022-2027) & (US$/Kg)
    Table 36. Global Mesalazine Sales by Application (2016-2021) & (Ton)
    Table 37. Global Mesalazine Sales by Application (2022-2027) & (Ton)
    Table 38. Global Mesalazine Sales Share by Application (2016-2021)
    Table 39. Global Mesalazine Sales Share by Application (2022-2027)
    Table 40. Global Mesalazine Revenue by Application (2016-2021) & (US$ Million)
    Table 41. Global Mesalazine Revenue by Application (2022-2027) & (US$ Million)
    Table 42. Global Mesalazine Revenue Share by Application (2016-2021)
    Table 43. Global Mesalazine Revenue Share by Application (2022-2027)
    Table 44. Mesalazine Price by Application (2016-2021) & (US$/Kg)
    Table 45. Global Mesalazine Price Forecast by Application (2022-2027) & (US$/Kg)
    Table 46. North America Mesalazine Sales by Type (2016-2021) & (Ton)
    Table 47. North America Mesalazine Sales by Type (2022-2027) & (Ton)
    Table 48. North America Mesalazine Revenue by Type (2016-2021) & (US$ Million)
    Table 49. North America Mesalazine Revenue by Type (2022-2027) & (US$ Million)
    Table 50. North America Mesalazine Sales by Application (2016-2021) & (Ton)
    Table 51. North America Mesalazine Sales by Application (2022-2027) & (Ton)
    Table 52. North America Mesalazine Revenue by Application (2016-2021) & (US$ Million)
    Table 53. North America Mesalazine Revenue by Application (2022-2027) & (US$ Million)
    Table 54. North America Mesalazine Sales by Country (2016-2021) & (Ton)
    Table 55. North America Mesalazine Sales by Country (2022-2027) & (Ton)
    Table 56. North America Mesalazine Revenue by Country (2016-2021) & (US$ Million)
    Table 57. North America Mesalazine Revenue by Country (2022-2027) & (US$ Million)
    Table 58. Europe Mesalazine Sales by Type (2016-2021) & (Ton)
    Table 59. Europe Mesalazine Sales by Type (2022-2027) & (Ton)
    Table 60. Europe Mesalazine Revenue by Type (2016-2021) & (US$ Million)
    Table 61. Europe Mesalazine Revenue by Type (2022-2027) & (US$ Million)
    Table 62. Europe Mesalazine Sales by Application (2016-2021) & (Ton)
    Table 63. Europe Mesalazine Sales by Application (2022-2027) & (Ton)
    Table 64. Europe Mesalazine Revenue by Application (2016-2021) & (US$ Million)
    Table 65. Europe Mesalazine Revenue by Application (2022-2027) & (US$ Million)
    Table 66. Europe Mesalazine Sales by Country (2016-2021) & (Ton)
    Table 67. Europe Mesalazine Sales by Country (2022-2027) & (Ton)
    Table 68. Europe Mesalazine Revenue by Country (2016-2021) & (US$ Million)
    Table 69. Europe Mesalazine Revenue by Country (2022-2027) & (US$ Million)
    Table 70. Asia Pacific Mesalazine Sales by Type (2016-2021) & (Ton)
    Table 71. Asia Pacific Mesalazine Sales by Type (2022-2027) & (Ton)
    Table 72. Asia Pacific Mesalazine Revenue by Type (2016-2021) & (US$ Million)
    Table 73. Asia Pacific Mesalazine Revenue by Type (2022-2027) & (US$ Million)
    Table 74. Asia Pacific Mesalazine Sales by Application (2016-2021) & (Ton)
    Table 75. Asia Pacific Mesalazine Sales by Application (2022-2027) & (Ton)
    Table 76. Asia Pacific Mesalazine Revenue by Application (2016-2021) & (US$ Million)
    Table 77. Asia Pacific Mesalazine Revenue by Application (2022-2027) & (US$ Million)
    Table 78. Asia Pacific Mesalazine Sales by Region (2016-2021) & (Ton)
    Table 79. Asia Pacific Mesalazine Sales by Region (2022-2027) & (Ton)
    Table 80. Asia Pacific Mesalazine Revenue by Region (2016-2021) & (US$ Million)
    Table 81. Asia Pacific Mesalazine Revenue by Region (2022-2027) & (US$ Million)
    Table 82. Latin America Mesalazine Sales by Type (2016-2021) & (Ton)
    Table 83. Latin America Mesalazine Sales by Type (2022-2027) & (Ton)
    Table 84. Latin America Mesalazine Revenue by Type (2016-2021) & (US$ Million)
    Table 85. Latin America Mesalazine Revenue by Type (2022-2027) & (US$ Million)
    Table 86. Latin America Mesalazine Sales by Application (2016-2021) & (Ton)
    Table 87. Latin America Mesalazine Sales by Application (2022-2027) & (Ton)
    Table 88. Latin America Mesalazine Revenue by Application (2016-2021) & (US$ Million)
    Table 89. Latin America Mesalazine Revenue by Application (2022-2027) & (US$ Million)
    Table 90. Latin America Mesalazine Sales by Country (2016-2021) & (Ton)
    Table 91. Latin America Mesalazine Sales by Country (2022-2027) & (Ton)
    Table 92. Latin America Mesalazine Revenue by Country (2016-2021) & (US$ Million)
    Table 93. Latin America Mesalazine Revenue by Country (2022-2027) & (US$ Million)
    Table 94. Middle East and Africa Mesalazine Sales by Type (2016-2021) & (Ton)
    Table 95. Middle East and Africa Mesalazine Sales by Type (2022-2027) & (Ton)
    Table 96. Middle East and Africa Mesalazine Revenue by Type (2016-2021) & (US$ Million)
    Table 97. Middle East and Africa Mesalazine Revenue by Type (2022-2027) & (US$ Million)
    Table 98. Middle East and Africa Mesalazine Sales by Application (2016-2021) & (Ton)
    Table 99. Middle East and Africa Mesalazine Sales by Application (2022-2027) & (Ton)
    Table 100. Middle East and Africa Mesalazine Revenue by Application (2016-2021) & (US$ Million)
    Table 101. Middle East and Africa Mesalazine Revenue by Application (2022-2027) & (US$ Million)
    Table 102. Middle East and Africa Mesalazine Sales by Country (2016-2021) & (Ton)
    Table 103. Middle East and Africa Mesalazine Sales by Country (2022-2027) & (Ton)
    Table 104. Middle East and Africa Mesalazine Revenue by Country (2016-2021) & (US$ Million)
    Table 105. Middle East and Africa Mesalazine Revenue by Country (2022-2027) & (US$ Million)
    Table 106. Syntese A/S Corporation Information
    Table 107. Syntese A/S Description and Major Businesses
    Table 108. Syntese A/S Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 109. Syntese A/S Mesalazine Product
    Table 110. Syntese A/S Recent Developments
    Table 111. Divis Laboratories Corporation Information
    Table 112. Divis Laboratories Description and Major Businesses
    Table 113. Divis Laboratories Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 114. Divis Laboratories Mesalazine Product
    Table 115. Divis Laboratories Recent Developments
    Table 116. Cambrex Corporation Corporation Information
    Table 117. Cambrex Corporation Description and Major Businesses
    Table 118. Cambrex Corporation Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 119. Cambrex Corporation Mesalazine Product
    Table 120. Cambrex Corporation Recent Developments
    Table 121. Ipca Laboratories Corporation Information
    Table 122. Ipca Laboratories Description and Major Businesses
    Table 123. Ipca Laboratories Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 124. Ipca Laboratories Mesalazine Product
    Table 125. Ipca Laboratories Recent Developments
    Table 126. PharmaZell Corporation Information
    Table 127. PharmaZell Description and Major Businesses
    Table 128. PharmaZell Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 129. PharmaZell Mesalazine Product
    Table 130. PharmaZell Recent Developments
    Table 131. Lasa Loboratory Corporation Information
    Table 132. Lasa Loboratory Description and Major Businesses
    Table 133. Lasa Loboratory Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 134. Lasa Loboratory Mesalazine Product
    Table 135. Lasa Loboratory Recent Developments
    Table 136. Erregierre SpA Corporation Information
    Table 137. Erregierre SpA Description and Major Businesses
    Table 138. Erregierre SpA Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 139. Erregierre SpA Mesalazine Product
    Table 140. Erregierre SpA Recent Developments
    Table 141. Corden Pharma Bergamo Corporation Information
    Table 142. Corden Pharma Bergamo Description and Major Businesses
    Table 143. Corden Pharma Bergamo Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 144. Corden Pharma Bergamo Mesalazine Product
    Table 145. Corden Pharma Bergamo Recent Developments
    Table 146. CTX Lifescience Corporation Information
    Table 147. CTX Lifescience Description and Major Businesses
    Table 148. CTX Lifescience Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 149. CTX Lifescience Mesalazine Product
    Table 150. CTX Lifescience Recent Developments
    Table 151. Ishita Active Pharma Ingredients Corporation Information
    Table 152. Ishita Active Pharma Ingredients Description and Major Businesses
    Table 153. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 154. Ishita Active Pharma Ingredients Mesalazine Product
    Table 155. Ishita Active Pharma Ingredients Recent Developments
    Table 156. YC Biotech (Jiangsu) Corporation Information
    Table 157. YC Biotech (Jiangsu) Description and Major Businesses
    Table 158. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 159. YC Biotech (Jiangsu) Mesalazine Product
    Table 160. YC Biotech (Jiangsu) Recent Developments
    Table 161. Xinxiang Tianfeng Fine Chemical Corporation Information
    Table 162. Xinxiang Tianfeng Fine Chemical Description and Major Businesses
    Table 163. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 164. Xinxiang Tianfeng Fine Chemical Mesalazine Product
    Table 165. Xinxiang Tianfeng Fine Chemical Recent Developments
    Table 166. Key Raw Materials Lists
    Table 167. Raw Materials Key Suppliers Lists
    Table 168. Mesalazine Distributors List
    Table 169. Mesalazine Customers List
    Table 170. Mesalazine Market Trends
    Table 171. Mesalazine Market Drivers
    Table 172. Mesalazine Market Challenges
    Table 173. Mesalazine Market Restraints
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mesalazine Product Picture
    Figure 2. Global Mesalazine Market Share by Type in 2020 & 2027
    Figure 3. Purity ≥ 97 % Product Picture
    Figure 4. Purity ≥ 98 % Product Picture
    Figure 5. Purity ≥ 99 % Product Picture
    Figure 6. Global Mesalazine Sales Market Share by Application in 2020 & 2027
    Figure 7. Mesalazine Tablets
    Figure 8. Mesalazine Capsules
    Figure 9. Others
    Figure 10. Mesalazine Report Years Considered
    Figure 11. Global Mesalazine Sales 2016-2027 (Ton)
    Figure 12. Global Mesalazine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Mesalazine Revenue 2016-2027 (US$ Million)
    Figure 14. Global Mesalazine Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 15. Global Mesalazine Sales Market Share by Region (2016-2021)
    Figure 16. Global Mesalazine Sales Market Share by Region (2022-2027)
    Figure 17. North America Mesalazine Sales YoY (2016-2027) & (Ton)
    Figure 18. North America Mesalazine Revenue YoY (2016-2027) & (US$ Million)
    Figure 19. Europe Mesalazine Sales YoY (2016-2027) & (Ton)
    Figure 20. Europe Mesalazine Revenue YoY (2016-2027) & (US$ Million)
    Figure 21. Asia-Pacific Mesalazine Sales YoY (2016-2027) & (Ton)
    Figure 22. Asia-Pacific Mesalazine Revenue YoY (2016-2027) & (US$ Million)
    Figure 23. Latin America Mesalazine Sales YoY (2016-2027) & (Ton)
    Figure 24. Latin America Mesalazine Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. Middle East & Africa Mesalazine Sales YoY (2016-2027) & (Ton)
    Figure 26. Middle East & Africa Mesalazine Revenue YoY (2016-2027) & (US$ Million)
    Figure 27. The Top 10 and Top 5 Players Market Share by Mesalazine Sales in 2020
    Figure 28. The Top 10 and Top 5 Players Market Share by Mesalazine Revenue in 2020
    Figure 29. Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 30. Global Mesalazine Sales Market Share by Type (2016-2027)
    Figure 31. Global Mesalazine Revenue Market Share by Type (2016-2027)
    Figure 32. Global Mesalazine Sales Market Share by Application (2016-2027)
    Figure 33. Global Mesalazine Revenue Market Share by Application (2016-2027)
    Figure 34. North America Mesalazine Sales Market Share by Type (2016-2027)
    Figure 35. North America Mesalazine Revenue Market Share by Type (2016-2027)
    Figure 36. North America Mesalazine Sales Market Share by Application (2016-2027)
    Figure 37. North America Mesalazine Revenue Market Share by Application (2016-2027)
    Figure 38. North America Mesalazine Sales Share by Country (2016-2027)
    Figure 39. North America Mesalazine Revenue Share by Country (2016-2027)
    Figure 40. U.S. Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 41. Canada Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 42. Europe Mesalazine Sales Market Share by Type (2016-2027)
    Figure 43. Europe Mesalazine Revenue Market Share by Type (2016-2027)
    Figure 44. Europe Mesalazine Sales Market Share by Application (2016-2027)
    Figure 45. Europe Mesalazine Revenue Market Share by Application (2016-2027)
    Figure 46. Europe Mesalazine Sales Share by Country (2016-2027)
    Figure 47. Europe Mesalazine Revenue Share by Country (2016-2027)
    Figure 48. Germany Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 49. France Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 50. U.K. Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 51. Italy Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 52. Russia Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 53. Asia Pacific Mesalazine Sales Market Share by Type (2016-2027)
    Figure 54. Asia Pacific Mesalazine Revenue Market Share by Type (2016-2027)
    Figure 55. Asia Pacific Mesalazine Sales Market Share by Application (2016-2027)
    Figure 56. Asia Pacific Mesalazine Revenue Market Share by Application (2016-2027)
    Figure 57. Asia Pacific Mesalazine Sales Share by Region (2016-2027)
    Figure 58. Asia Pacific Mesalazine Revenue Share by Region (2016-2027)
    Figure 59. China Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 60. Japan Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 61. South Korea Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 62. India Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 63. Australia Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 64. Taiwan Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 65. Indonesia Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 66. Thailand Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 67. Malaysia Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 68. Philippines Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 69. Latin America Mesalazine Sales Market Share by Type (2016-2027)
    Figure 70. Latin America Mesalazine Revenue Market Share by Type (2016-2027)
    Figure 71. Latin America Mesalazine Sales Market Share by Application (2016-2027)
    Figure 72. Latin America Mesalazine Revenue Market Share by Application (2016-2027)
    Figure 73. Latin America Mesalazine Sales Share by Country (2016-2027)
    Figure 74. Latin America Mesalazine Revenue Share by Country (2016-2027)
    Figure 75. Mexico Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 76. Brazil Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 77. Argentina Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 78. Middle East and Africa Mesalazine Sales Market Share by Type (2016-2027)
    Figure 79. Middle East and Africa Mesalazine Revenue Market Share by Type (2016-2027)
    Figure 80. Middle East and Africa Mesalazine Sales Market Share by Application (2016-2027)
    Figure 81. Middle East and Africa Mesalazine Revenue Market Share by Application (2016-2027)
    Figure 82. Middle East and Africa Mesalazine Sales Share by Country (2016-2027)
    Figure 83. Middle East and Africa Mesalazine Revenue Share by Country (2016-2027)
    Figure 84. Turkey Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 85. Saudi Arabia Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 86. U.A.E Mesalazine Revenue (2016-2027) & (US$ Million)
    Figure 87. Mesalazine Value Chain
    Figure 88. Mesalazine Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Frequently Asked Questions
Mesalazine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Mesalazine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Mesalazine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Transparent Screen

Transparent Screen market is segmented by Type, and by Application. Players, stakeholders, and ot ... Read More

GMP Cytokines

GMP Cytokines market is segmented by Type, and by Application. Players, stakeholders, and other p ... Read More

Cable Cleats

Cable Cleats market is segmented by Type, and by Application. Players, stakeholders, and other pa ... Read More